Bio Solution Co.,Ltd. Logo

Bio Solution Co.,Ltd.

Develops cell therapies, human tissue models, and bio-laboratory products.

086820 | KO

Overview

Corporate Details

ISIN(s):
KR7086820008
LEI:
Country:
South Korea
Address:
서울특별시 노원구 공릉로 232 5층 (공릉동, 서울테크노파크), 서울특별시

Description

Bio Solution Co., Ltd. is a biotechnology company focused on the development, manufacturing, and sale of cell therapy products. The company's core activities involve cell-based biotechnology, producing therapeutics such as autologous chondrocyte treatments for cartilage regeneration. In addition to its therapeutic offerings, Bio Solution develops human tissue models and provides alternative testing solutions. The company also manufactures and distributes a portfolio of bio-laboratory products, including ready-to-use kits, staining solutions, and various reagents for molecular biology research and development applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.3 KB
2025-09-17 00:00
투자판단관련주요경영사항(임상시험계획승인신청) (펠렛형 동종 연골세포치료제(카티로이드)의 호주 제1/2상 임상시험계획 승…
Korean HTML 8.9 KB
2025-08-25 00:00
기업설명회(IR)개최
Korean HTML 6.8 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.5 MB
2025-07-01 00:00
금전대여결정
Korean HTML 19.4 KB
2025-06-05 00:00
기업설명회(IR)개최
Korean HTML 6.7 KB
2025-06-05 00:00
투자판단관련주요경영사항 (펠렛형 동종 연골세포치료제(카티로이드)의 제1/2상 임상시험계획 승인신청 반려)
Korean HTML 8.8 KB
2025-05-30 00:00
기업설명회(IR)개최
Korean HTML 6.7 KB
2025-05-29 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 27.7 KB
2025-05-26 00:00
권리락 (무상증자)
Korean HTML 3.5 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean HTML 880.1 KB
2025-05-13 00:00
주권매매거래정지 (무상증자)
Korean HTML 4.8 KB
2025-05-13 00:00
주요사항보고서(무상증자결정)
Korean HTML 12.0 KB
2025-05-13 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.4 KB
2025-05-09 00:00
기업설명회(IR)개최
Korean HTML 6.8 KB

Automate Your Workflow. Get a real-time feed of all Bio Solution Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bio Solution Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bio Solution Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.